Workflow
Bitcoin price to $1.4m by 2035, Kraken-backed research firm says
Yahoo Finance· 2025-12-19 09:34
Bitcoin is heading to a $1.4 million price by the year 2035, according to research firm CF Benchmarks. Analysts Gabriel Selby and Mark Pilipczuk said in a new report that the top crypto will capture one-third of the global store-of-value market, rallying 1,500% from its price of $88,000 at time of reporting. Investors can expect an “asymmetrical return” from buying Bitcoin, which “fundamentally distinguishes it from traditional asset classes,” the pair wrote. At the same time, volatility is expected to ...
GM Eyes Ex-Tesla Autopilot Exec Sterling Anderson As Potential CEO Successor To Mary Barra: Report - General Motors (NYSE:GM)
Benzinga· 2025-12-19 09:32
General Motors Co. (NYSE:GM) is reportedly eyeing its current Chief Product Officer, Sterling Anderson, who was also formerly a Tesla Inc. (NASDAQ:TSLA) Autopilot exec and co-founder of Aurora Innovation Inc. (NASDAQ:AUR) , as the company's next CEO.Check out the current price of GM Stock here.Sterling Anderson To Succeed Mary Barra?Anderson could be gearing up to succeed GM's current CEO, Mary Barra, according to a report by Bloomberg on Thursday. The report suggests that Anderson could replace Barra if he ...
What to Expect From Citizens Financial's Q4 2025 Earnings Report
Yahoo Finance· 2025-12-19 09:32
Providence, Rhode Island-based Citizens Financial Group, Inc. (CFG) provides retail and commercial banking products and services. Valued at $25.2 billion by market cap, CFG offers consumer and commercial loans, mortgage finance, deposit products, retail and commercial banking, asset management, and trust services. The bank holding company is expected to announce its fiscal fourth-quarter earnings for 2025 in the near future. Ahead of the event, analysts expect CFG to report a profit of $1.12 per share on ...
Coca-Cola India FY25 profit rises 46.3% to ₹615 cr, revenue at ₹5,042.56 cr
BusinessLine· 2025-12-19 09:32
Beverages major Coca-Cola India's has posted a 46.3 per cent rise in consolidated profit to ₹615.03 crore in FY25, while its revenue from operations was ₹5,042.56 crore, up 7 per cent.Its total income, which includes other income, increased 7.7 per cent to ₹5,171.48 crore for the financial year ended March 31, 2025, according to financial data accessed through business intelligence platform Tofler.Coca-Cola India Pvt Ltd's net profit was ₹420.3 crore, and its revenue from operations was at ₹4,713.38 crore i ...
WuXi Biologics Achieves CDP Highest "A" Ratings in Both Climate Change and Water Security
Prnewswire· 2025-12-19 09:30
Core Viewpoint - WuXi Biologics has been recognized with "A" ratings by CDP for both Climate Change and Water Security in 2025, highlighting its commitment to environmental stewardship and transparency [1] Climate Change Leadership - The "A" rating for Climate Change reflects WuXi Biologics' strong environmental performance and its validated integrated climate change strategy, aiming for net-zero emissions across its value chain by 2050 [2] - The company has implemented initiatives such as energy efficiency programs, process optimization, and renewable energy adoption, with its biologics facility in Ireland operating on 100% renewable electricity [2] Water Security Excellence - WuXi Biologics has achieved a place on the CDP Water Security "A" List for the third consecutive year, demonstrating its commitment to sustainable water management [3] - The company aims to reduce water consumption intensity by 30% by the end of 2025 compared to a 2019 baseline and has launched a Water Excellence Stewardship program covering various aspects of water management [3] Supplier Engagement - Earlier in the year, WuXi Biologics received an "A" rating in the CDP's Supplier Engagement assessment, recognizing its efforts to drive climate action across its value chain [4] - The company collaborates with global suppliers to promote a sustainable economy through a comprehensive supply chain management system and Scope 3 emissions tracking [4] Leadership Commentary - Dr. Chris Chen, CEO of WuXi Biologics, expressed pride in receiving the "A" ratings, reinforcing the company's commitment to sustainability and its role as a leader in green biologics [5] Industry Recognition - WuXi Biologics has received multiple accolades for its sustainability efforts, including an MSCI AAA Rating, EcoVadis Platinum Medal, and recognition in various sustainability indices [5] Company Overview - WuXi Biologics is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) providing end-to-end solutions for biologics [6] - The company employs over 12,000 skilled professionals across multiple countries and supports 864 integrated client projects, including 24 in commercial manufacturing as of June 30, 2025 [7] Commitment to Sustainability - The company views sustainability as essential for long-term growth and continuously innovates in green technology to provide advanced CRDMO solutions [8]
Hong Kong stocks cap longest rising streak in 3 weeks on cooling US inflation data
Yahoo Finance· 2025-12-19 09:30
Hong Kong stocks rose for a third day on Friday, sending the benchmark gauge to its longest winning streak in three weeks, after softer US inflation data bolstered the case for monetary easing and allayed concerns about frothy valuations of global equities. The Hang Seng Index advanced 0.8 per cent to 25,690.53 at the close, paring the weekly loss to 1.1 per cent. The Hang Seng Tech Index gained 1.1 per cent. On the mainland, the CSI 300 Index climbed 0.3 per cent and the Shanghai Composite Index added 0. ...
Tech pivot: Chinese AI, chip start-ups court global investors with Hong Kong listing plans
Yahoo Finance· 2025-12-19 09:30
More Chinese artificial intelligence firms and chipmakers are turning to Hong Kong for fundraising, testing the appetite of global investors following stellar onshore debuts of graphics processing unit (GPU) developers Moore Threads Technology and MetaX Integrated Circuits. GigaDevice Semiconductor is a step closer to its Hong Kong initial public offering (IPO) after passing a listing hearing, according to bourse operator Hong Kong Exchanges and Clearing (HKEX). The company is expected to reactivate its I ...
What Has General Motors (GM) Stock Done for Investors?
The Motley Fool· 2025-12-19 09:30
Core Insights - General Motors (GM) has shown strong performance in the investment community, with a trailing-12-month revenue of $187 billion and 1.6 million units sold in the latest quarter [1] Financial Performance - Over the past five years, GM shares have produced a total return of 101%, matching the performance of the S&P 500 [3] - In the past 12 months and three years, GM has achieved total returns of 56% and 117%, respectively, with the stock currently trading at an all-time high [4] - GM reported adjusted EPS of $2.80 and revenue of $48.6 billion for the third quarter of 2025, exceeding Wall Street estimates for 13 consecutive quarters [6] Market Position and Strategy - The belief that electric vehicles would rapidly dominate the market has not materialized, reducing a key risk factor for GM, which primarily generates revenue from gas-powered cars [5] - GM's leadership has implemented a capital allocation policy that allows for stock buybacks, reducing the outstanding share count by 15% in the past 12 months [7] Valuation Metrics - Despite strong performance, GM's stock is trading at a forward price-to-earnings ratio of 6.9, indicating an attractive valuation [8] Market Challenges - GM faces cyclical demand trends, significant capital expenditures, low margins, and intense competition, which may temper investor enthusiasm [9]
China's pharmaceutical sector moves into the big leagues as a global innovation powerhouse
Yahoo Finance· 2025-12-19 09:30
China is gaining a solid reputation as a pharmaceutical innovation hub, shifting from a copycat drug maker to one whose infrastructure and research and development capabilities rival global pharmaceutical behemoths, according to a global consultancy. US-based SAI MedPartners and its unit Idea Pharma recently launched a new index with the aim of highlighting Chinese drug makers and recognising their shift from generics to "true" innovation. The consultancy released the China Pharmaceutical Innovation and ...
Need for speed: Alibaba ramps up China instant commerce push with Cainiao and Tmall tie-up
Yahoo Finance· 2025-12-19 09:30
Alibaba Group's logistics arm Cainiao and online grocery business Tmall Supermarket are teaming up to expand fulfilment infrastructure and speed up deliveries, as the Chinese e-commerce giant ramps up its efforts in China's fast-growing instant commerce battle to fend off rivals such as JD.com and Meituan. Cainiao will launch new or expand instant commerce warehouses for Tmall Supermarket across 31 mainland Chinese cities by the end of January 2026, it said in a statement on Thursday. Alibaba owns the Pos ...